Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
30.06.23
/
50%
€12.81
Target price
30.06.24
€15.60
Performance (%)
-87.51%
Price
22:26
€1.60
Summary
This prediction is currently active. Massive losses of -87.51% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 30.06.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 0.542% | 0.542% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.26
10.04.24
10.04.24
€6.50
10.04.25
10.04.25
-50.93%
22:26
22:26